SEC Form 4 · accession 0001127602-18-003628
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul A Mahon
Officer — EVP & General Counsel
Period of report
Feb 1, 2018
Accepted (ET)
Feb 2, 2018 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 1, 2018 | M | 6,000 | $61.06 | A | 41,426 | D | |
| Common Stock | Feb 1, 2018 | D | 6,000 | $136.49 | D | 35,426 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking AwardF2 | $61.06 | Feb 1, 2018 | M | 6,000 | D | Mar 15, 2014 | Mar 15, 2023 | Common Stock | 6,000 | 103,000 | D |
Explanation of responses
- F1This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F2These share tracking awards vest in one-fourth increments on each of March 14, 2015, 2016, 2017 and 2018, and settle in cash only.